Changeflow GovPing Healthcare & Life Sciences EP4090407A1 Guidewire Positioning, Ancora Heart
Routine Rule Added Final

EP4090407A1 Guidewire Positioning, Ancora Heart

Favicon for changeflow.com EPO Patent Bulletin - Medical Devices (A61M)
Published
Detected
Email

Summary

The European Patent Office published patent application EP4090407A1 titled 'Devices and Methods for Positioning a Guidewire' filed by Ancora Heart, Inc. The application, published April 15, 2026, covers guidewire positioning technology under IPC classification A61M 25/09. Designated states include all EU member states plus associated countries (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR).

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors EPO Patent Bulletin - Medical Devices (A61M) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 66 changes logged to date.

What changed

The EPO published patent application EP4090407A1 for Ancora Heart, Inc., covering devices and methods for positioning a guidewire under IPC classification A61M 25/09. The application names Rob Kotmel as inventor and designates all EU member states plus associated countries. Patent applications are published to establish priority rights and allow third parties to oppose or observe.

Medical device manufacturers developing guidewire-based technologies should review the published claims to assess potential freedom-to-operate implications in the EU market. The designated states coverage means the patent, if granted, could affect commercialization across all listed territories. Competitors in the cardiac and vascular access device space should monitor this application's prosecution.

Archived snapshot

Apr 26, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

DEVICES AND METHODS FOR POSITIONING A GUIDEWIRE

Publication EP4090407A1 Kind: A1 Apr 15, 2026

Applicants

Ancora Heart, Inc.

Inventors

KOTMEL, Rob

IPC Classifications

A61M 25/09 20060101AFI20240116BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Medical Devices (A61M)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 15th, 2026
Instrument
Rule
Branch
International
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP4090407A1

Who this affects

Applies to
Medical device makers Healthcare providers Clinical investigators
Industry sector
3345 Medical Device Manufacturing
Activity scope
Patent examination IP licensing Medical device development
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Medical Devices Healthcare

Get alerts for this source

We'll email you when EPO Patent Bulletin - Medical Devices (A61M) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!